KILITCHBuy above:- 213
Stop Loss:- 165
Target:- 260
Time :- 45 trading days
The company is based on pharmaceutical company it is engaged in the manufacturing and sale of pharmaceutical products
9.20INR
104.48 MINR
1.40 BINR
4.21 M
About KILITCH DRUGS (INDIA) LTD.
Sector
CEO
Mukund Prataprai Mehta
Headquarters
Mumbai
Website
Employees (FY)
165
Founded
1978
ISIN
INE729D01010
FIGI
BBG000D4WH58
Kilitch Drugs (India) Ltd. engages in the developing, manufacturing, and marketing of pharmaceuticals, medicinal chemical, and botanical products. Its products include oral, parenterals and nasal, and nutritional products. The company was founded by Pratap Keshavji Mehta in 1978 and is headquartered in Mumbai, India.
KILITCH - C & H patternKILITCH
CMP 157
Spotted slightly late / Buying suggested on retracements 145-155
Stop 125
Target - Open
Logic :
Techncials:
C&H sort of pattern observed with Volume replicating the price pattern;
Breakout happened with huge volumes (@ 138).
Fundamentals:
Exponential growth in fundamental paramet
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of KILITCH is 351.15 INR — it has decreased by 0.66% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange KILITCH DRUGS (INDIA) LTD. stocks are traded under the ticker KILITCH.
KILITCH DRUGS (INDIA) LTD. is going to release the next earnings report on May 24, 2024. Keep track of upcoming events with our Earnings Calendar.
KILITCH stock is 1.94% volatile and has beta coefficient of 0.46. Check out the list of the most volatile stocks — is KILITCH DRUGS (INDIA) LTD. there?
Yes, you can track KILITCH DRUGS (INDIA) LTD. financials in yearly and quarterly reports right on TradingView.
KILITCH stock has fallen by 5.15% compared to the previous week, the month change is a 2.24% fall, over the last year KILITCH DRUGS (INDIA) LTD. has showed a 120.85% increase.
KILITCH net income for the last quarter is 29.09 M INR, while the quarter before that showed 47.41 M INR of net income which accounts for −38.64% change. Track more KILITCH DRUGS (INDIA) LTD. financial stats to get the full picture.
Today KILITCH DRUGS (INDIA) LTD. has the market capitalization of 5.69 B, it has decreased by 3.73% over the last week.
KILITCH DRUGS (INDIA) LTD. dividend yield was 0% in 2022, and payout ratio reached 0%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, KILITCH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KILITCH DRUGS (INDIA) LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 165.00 employees. See our rating of the largest employees — is KILITCH DRUGS (INDIA) LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KILITCH DRUGS (INDIA) LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KILITCH DRUGS (INDIA) LTD. stock shows the buy signal. See more of KILITCH DRUGS (INDIA) LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KILITCH DRUGS (INDIA) LTD. EBITDA is 232.91 M INR, and current EBITDA margin is 12.95%. See more stats in KILITCH DRUGS (INDIA) LTD. financial statements.